Limited comparability of creatinine assays in patients with liver cirrhosis and their impact on the MELD score

BACKGROUND & AIM: Patients with end-stage liver disease require valid estimations of mortality for organ allocation and risk stratification. The model of end-stage liver disease (MELD) score is used for this purpose in most countries and incorporates bilirubin, International Normalized ratio, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaiser, Thorsten, Kinny-Köster, Benedict, Gnewuch, Carsten, Karailieva, Diana, Kiehntopf, Michael, Kessler, Anja, Ritter-Sket, Christina, Schmidt, Michael, Brand, Korbinian, Thiery, Joachim, Lichtinghagen, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575426/
https://www.ncbi.nlm.nih.gov/pubmed/28856226
http://dx.doi.org/10.1016/j.plabm.2017.04.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575426/
https://www.ncbi.nlm.nih.gov/pubmed/28856226
http://dx.doi.org/10.1016/j.plabm.2017.04.002

Ejemplares similares